Clinical trials: Pharmacokinetics of Caffeine

Hypoxic-Ischemic Encephalopathy

Caffeine for Hypoxic-Ischemic Encephalopathy

• Completed
• Age: Up to 24 hours
• Phase 1
• Results posted

Hypoxic-ischemic encephalopathy (HIE) due to perinatal asphyxia is common and often fatal. Therapeutic hypothermia reduces mortality and morbidity in infants with HIE.

Trial name

NCT03913221

Testing

Caffeine Citrate 5 mg/kg, Caffeine Citrate 10 mg/kg

Where

United States

Volunteers

17 people

Sponsor

University of North Carolina, Chapel Hill